INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 3 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $48 | +29.7% | 94 | 0.0% | 0.00% | – |
| Q3 2023 | $37 | -11.9% | 94 | 0.0% | 0.00% | – |
| Q2 2023 | $42 | -45.5% | 94 | 0.0% | 0.00% | – |
| Q1 2023 | $77 | -47.6% | 94 | 0.0% | 0.00% | – |
| Q4 2022 | $147 | – | 94 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 94 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 94 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 94 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 94 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 94 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 94 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
| Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
| Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
| SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
| Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
| GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
| WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
| EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
| Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
| Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |